Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Clinical trial NCT00779285 · TERMINATED

Trial details

NCT number: NCT00779285
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Neoplasm

Start date: 2006-02-01
Primary completion: 2006-08-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.